Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b

Human vitamin D3 hydroxylase (CYP24) catalyzes the inactivation of 1α,25-dihydroxyvitamin D3 (calcitriol), which exerts antiproliferative effects. CYP24 has been reported to be overexpressed in various cancers in which microRNA levels are dysregulated. In silico analysis identified a potential miR-125b recognition element (MRE125b) in the 3′-untranslated region of human CYP24 mRNA. We investigated whether CYP24 is regulated by miR-125b. In luciferase assays using a reporter plasmid containing MRE125b, transfection of the antisense oligonucleotide (AsO) for miR-125b increased the reporter activity in KGN cells, and transfection of precursor miR-125b decreased the reporter activity in MCF-7 cells. The endogenous CYP24 protein level was also increased by AsO for miR-125b in KGN cells and was decreased by precursor miR-125b in MCF-7 cells. These results suggested that human CYP24 is regulated by miR-125b. Immunohistochemical analysis revealed that the CYP24 protein levels in human breast cancer were higher than in adjacent normal tissues, without an accompanying CYP24 mRNA increase. On the other hand, the expression levels of miR-125b in cancer tissues were significantly (P < 0.0005) lower than those in normal tissues. It is noteworthy that the CYP24 protein levels in cancer tissues were inversely associated with the cancer/normal ratios of the miR-125b levels, indicating that the decreased miR-125b levels in breast cancer tissues would be one of the causes of the high CYP24 protein expression. In conclusion, this study clearly demonstrates that miR-125b post-transcriptionally regulates the CYP24, which serves as a possible mechanism for the high CYP24 expression in cancer tissues.

[1]  Danish Sayed,et al.  MicroRNAs in development and disease. , 2011, Physiological reviews.

[2]  Shingo Takagi,et al.  MicroRNA regulates human vitamin D receptor , 2009, International journal of cancer.

[3]  T. Down,et al.  Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene , 2009, Journal of Biological Chemistry.

[4]  Yan Zhao,et al.  Effects of MAPK signaling on 1,25‐dihydroxyvitamin D‐mediated CYP24 gene expression in the enterocyte‐like cell line, Caco‐2 , 2009, Journal of cellular physiology.

[5]  M. Negishi,et al.  Nuclear Xenobiotic Receptor Pregnane X Receptor Locks Corepressor Silencing Mediator for Retinoid and Thyroid Hormone Receptors (SMRT) onto the CYP24A1 Promoter to Attenuate Vitamin D3 Activation , 2009, Molecular Pharmacology.

[6]  Yan Zeng,et al.  Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2008, Carcinogenesis.

[7]  Jianren Gu,et al.  Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma , 2008, International journal of cancer.

[8]  C. Croce,et al.  MicroRNAs in diseases and drug response. , 2008, Current opinion in pharmacology.

[9]  Kiyoshi Yanagisawa,et al.  Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11‐21 in human lung cancer , 2008, Genes, chromosomes & cancer.

[10]  Frank J. Slack,et al.  MicroRNAs and cancer: An overview , 2008, Cell cycle.

[11]  Y. Okazaki,et al.  miR-125b inhibits osteoblastic differentiation by down-regulation of cell proliferation. , 2008, Biochemical and biophysical research communications.

[12]  C. Croce,et al.  Specific microRNAs are downregulated in human thyroid anaplastic carcinomas , 2007, Oncogene.

[13]  D. Trump,et al.  Vitamin D signalling pathways in cancer: potential for anticancer therapeutics , 2007, Nature Reviews Cancer.

[14]  J. Pascussi,et al.  Constitutive androstane receptor-vitamin D receptor crosstalk: consequence on CYP24 gene expression. , 2007, Biochemical and biophysical research communications.

[15]  N. Nowak,et al.  Epigenetic Silencing of CYP24 in Tumor-derived Endothelial Cells Contributes to Selective Growth Inhibition by Calcitriol* , 2007, Journal of Biological Chemistry.

[16]  C. Benz,et al.  Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.

[17]  Kenny Q. Ye,et al.  Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.

[18]  S. Takagi,et al.  MicroRNA regulates the expression of human cytochrome P450 1B1. , 2006, Cancer research.

[19]  M. Brentani,et al.  25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1α-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer , 2006, The Journal of Steroid Biochemistry and Molecular Biology.

[20]  John G Doench,et al.  Recapitulation of short RNA-directed translational gene silencing in vitro. , 2006, Molecular cell.

[21]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Croce,et al.  MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.

[23]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[24]  M. Guy,et al.  Autocrine Metabolism of Vitamin D in Normal and Malignant Breast Tissue , 2005, Clinical Cancer Research.

[25]  Kwang-Soo Kim,et al.  Depletion of Human Micro-RNA miR-125b Reveals That It Is Critical for the Proliferation of Differentiated Cells but Not for the Down-regulation of Putative Targets during Differentiation* , 2005, Journal of Biological Chemistry.

[26]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[27]  Pascal G. P. Martin,et al.  Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. , 2005, The Journal of clinical investigation.

[28]  S. Kyo,et al.  Human CYP1B1 is regulated by estradiol via estrogen receptor. , 2004, Cancer research.

[29]  C. Croce,et al.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Takaaki Masuda,et al.  Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[32]  W. Kuo,et al.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene , 2000, Nature Genetics.

[33]  H. DeLuca,et al.  Cloning of the human 1 alpha,25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. , 1995, Biochimica et biophysica acta.

[34]  G. Hampton,et al.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.

[35]  J Piper,et al.  Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Xiaoan Ruan,et al.  Expression of VDR and CYP24A1 mRNA in human tumors , 2005, Cancer Chemotherapy and Pharmacology.

[37]  Y. Nishi,et al.  Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. , 2001, Endocrinology.

[38]  Placental methylation of Vitamin D 24-hydroxylase gene PLACENTA SPECIFIC METHYLATION OF THE VITAMIN D 24-HYDROXYLASE GENE: IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE. , 2022 .